A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
针对 IDO/PD-L1 的免疫调节疫苗与 nivolumab 联合治疗转移性黑色素瘤的 1/2 期临床试验
期刊:Nature Medicine
影响因子:58.7
doi:10.1038/s41591-021-01544-x
Julie Westerlin Kjeldsen #, Cathrine Lund Lorentzen #, Evelina Martinenaite, Eva Ellebaek, Marco Donia, Rikke Boedker Holmstroem, Tobias Wirenfeldt Klausen, Cecilie Oelvang Madsen, Shamaila Munir Ahmed, Stine Emilie Weis-Banke, Morten Orebo Holmström, Helle Westergren Hendel, Eva Ehrnrooth, Mai-Brit
